Live Breaking News & Updates on Crinetics Pharmaceuticals Company Profile|Page 3

Stay updated with breaking news from Crinetics pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Director Stephanie Okey Sells 17,500 Shares

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) Director Stephanie Okey sold 17,500 shares of Crinetics Pharmaceuticals stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $46.38, for a total value of $811,650.00. Following the completion of the sale, the director now owns 6,000 shares of the […] ....

Robertw Baird , Stephanie Okey , Morgan Stanley , China Universal Asset Management Co , Osaic Holdings Inc , Cantor Fitzgerald , News Ratings For Crinetics Pharmaceuticals Daily , Crinetics Pharmaceuticals Company Profile , Quarter For Crinetics Pharmaceuticals , Tower Research Capital , Crinetics Pharmaceuticals , Crinetics Pharmaceuticals Stock Performance , Crinetics Pharmaceuticals Inc , Hedge Funds Weigh In On Crinetics Pharmaceuticals , Get Free Report , Director Stephanie Okey , Research Capital , Universal Asset Management , Crinetics Pharmaceuticals Daily , Nasdaq Crnx , Insider Trading , Nsider Trades ,

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Director Sells $811,650.00 in Stock

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) Director Stephanie Okey sold 17,500 shares of the business’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $46.38, for a total transaction of $811,650.00. Following the completion of the sale, the director now owns 6,000 shares in the […] ....

Robertw Baird , Stephanie Okey , Crinetics Pharmaceuticals , Vivo Capital , Hedge Funds Weigh In On Crinetics Pharmaceuticals , Cantor Fitzgerald , Crinetics Pharmaceuticals Inc , Quarter For Crinetics Pharmaceuticals , Campbell Co Investment Adviser , Crinetics Pharmaceuticals Company Profile , Jefferies Financial Group , Swiss National Bank , Crinetics Pharmaceuticals Stock Performance , Charles Schwab Investment Management Inc , Victory Capital Management Inc , News Ratings For Crinetics Pharmaceuticals Daily , Get Free Report , Director Stephanie Okey , Financial Group , Schwab Investment Management , Capital Management , National Bank , Crinetics Pharmaceuticals Daily , Nasdaq Crnx , Insider Trading , Nsider Trades ,

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Sees Large Increase in Short Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Sees Large Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New Zealand General , New Zealand , Stephenf Betz , Marc Wilson , News Ratings For Crinetics Pharmaceuticals Daily , Wellington Management Group , Crinetics Pharmaceuticals Company Profile , Crinetics Pharmaceuticals , Pricet Rowe Associates Inc , Crinetics Pharmaceuticals Inc , Jennison Associates , Vanguard Group Inc , Securities Exchange Commission , Institutional Trading Of Crinetics Pharmaceuticals , Blackrock Inc , Crinetics Pharmaceuticals Trading , Morgan Stanley , Get Free Report , Exchange Commission , Management Group , Crinetics Pharmaceuticals Daily ,

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Update

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 5,010,000 shares, an increase of 5.7% from the February 29th total of 4,740,000 shares. Based on an average daily volume of 745,500 shares, […] ....

Stephenf Betz , Marc Wilson , Morgan Stanley , Blackrock Inc , Institutional Investors Weigh In On Crinetics Pharmaceuticals , Crinetics Pharmaceuticals Stock , Securities Exchange Commission , Cantor Fitzgerald , Jennison Associates , Crinetics Pharmaceuticals Inc , Vanguard Group Inc , Jefferies Financial Group , Crinetics Pharmaceuticals , Crinetics Pharmaceuticals Company Profile , News Ratings For Crinetics Pharmaceuticals Daily , Get Free Report , Exchange Commission , Avidity Partners Management , Financial Group , Crinetics Pharmaceuticals Daily ,

Jonestrading Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $56.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target raised by Jonestrading from $52.00 to $56.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on CRNX. Citigroup started coverage on Crinetics Pharmaceuticals in a research […] ....

Matthewk Fust , Dana Pizzuti , Robertw Baird , Crinetics Pharmaceuticals Stock Down , Victory Capital Management Inc , Securities Exchange Commission , Campbell Co Investment Adviser , Crinetics Pharmaceuticals Company Profile , Charles Schwab Investment Management Inc , Cantor Fitzgerald , Crinetics Pharmaceuticals Inc , Crinetics Pharmaceuticals , News Ratings For Crinetics Pharmaceuticals Daily , Vivo Capital , Analyst Recommendations For Crinetics Pharmaceuticals , Swiss National Bank , Free Report , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Director Matthew , Exchange Commission , Schwab Investment Management , National Bank , Victory Capital Management , Crinetics Pharmaceuticals Daily ,